VIRBAC: Une marge opérationnelle2 solide de 18,8 %, portée par une croissance soutenue du chiffre d'affaires de +7,4 %

Summary

VIRBAC reported solid first-half 2026 results with revenue growth of 7.4% and an operating margin of 18.8%, bolstered by organic sales growth. The company completed an acquisition of Thyronorm, integrated into organic scope.